Clinical Trial Update: Does Treatment With Alfuzosin Increase Success Rates of (SWL) Shock Wave Lithotripsy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial investigates whether Alfuzosin increases the success rate of shock wave lithotripsy for urinary stones.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nephrolithiasis
• Ureterolithiasis
• Urolithiasis

Drugs mentioned

• Alfuzosin (alfuzosin)

Snippet

Sponsor: Assaf-Harofeh Medical Center | Conditions: Urolithiasis, Nephrolithiasis | Phase 2 | Status: UNKNOWN